Evidence map›Paper›PMID 40129653›Full record

ArticleFrontiers in veterinary science2024

Case report: Endolymphatic system disease in elasmobranchs: clinical presentation, diagnosis, and treatment strategies.

Whitney Greene, Nuno Pereira, Bethany Doescher, Carlos Rojo-Solis, Hugo David, Ricardo Faustino, David Reese, Ryan De Voe, Ed Latson, Natalie Mylniczenko

Abstract readCase Reports
In one paragraph

Article in Frontiers in veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Whitney Greene *Mote Marine Laboratory and Aquarium, Sarasota, FL, United States.
Nuno PereiraOceanário de Lisboa, Esplanada D. Carlos I, Lisbon, Portugal.
Bethany DoescherSea Life Park Hawaii, Waimanalo, HI, United States.
Carlos Rojo-SolisOceanogràfic, Ciudad de las Artes y las Ciencias, Valencia, Spain.
Hugo DavidOceanário de Lisboa, Esplanada D. Carlos I, Lisbon, Portugal.
Ricardo FaustinoResearch Unit in Medical Imaging and Radiotherapy, Cross I&D Lisbon Research Center, Escola Superior de Saúde da Cruz Vermelha Portuguesa, Lisbon, Portugal.
David ReeseVetCT Consultants in Telemedicine PTY LTD., Applecross, WA, Australia.
Ryan De VoeDisney Animals, Science and Environment, Disney's Animal Kingdom® and the Seas with Nemo and Friends®, Lake Buena Vista, FL, United States.
Ed LatsonAquarium of Niagara, Niagara Falls, NY, United States.
Natalie Mylniczenko *Disney Animals, Science and Environment, Disney's Animal Kingdom® and the Seas with Nemo and Friends®, Lake Buena Vista, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The inner ear is an often overlooked system in elasmobranchs with few documented reports of disease or other abnormalities in the literature. Similar to terrestrial vertebrates, it is located in the cranium, and there are multiple components to the ear of elasmobranchs including a pair of membranous labyrinths each with three semicircular canals and four chambers or end organs (the saccule, the lagena, the utricle and the macula neglecta) making up the endolymphatic system (ELS). There is species variability among the inner ear anatomy of elasmobranchs, and this may play a role in disease development, progression, and treatment outcomes. Also similar to terrestrial vertebrates, this system plays a key role in hearing, acceleration, and orientation. When affected, clinical signs may include localized areas of swelling or stoma development along the dorsal midline of the head at the endolymphatic pores, atypical swimming behaviors consistent with vestibular disease (spiraling/spinning or barrel rolling, or tilting to one side), and anorexia. Less frequently, the eyes may also be affected and present with exophthalmia, hyphema, and/or panophthalmitis. Herein are case series from five institutions representing a variety of elasmobranch species affected with ELS disease with discussion of anatomy, clinical presentation, diagnostics, etiology, treatment, and outcomes. Endolymphatic disease may be clinically underdiagnosed in elasmobranchs and mistaken for other diseases such as superficial subcutaneous or subdermal abscesses, focal dermatitis, or neuropathies presumed to not be associated with the inner ear system. In addition, disease may be occult for a long period of time prior to overt manifestation of signs or chronic with waxing and waning clinical signs, likely because of anatomy and resultant treatment challenges. Awareness and additional research may help to promote timely identification, improve diagnostic and treatment options, and help to optimize individual animal welfare.

Indexed as

endolymphatic poreinner earlabyrinthitisneurologic diseaseneuropathyotic diseasesharkstingray

Identifiers

PMID40129653
PMCPMC11931651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.